Aktiesnakken — September 2013
-
-
Solsen skal man samle QCOR op igen ? den er røget ned i 55 fra 70 nu
-
Tror dog jeg holder mig væk, da der har været massive insidersalg
-
ja det er den bedste rettesnor
-
lidt om os
-
-
Tja, morphosis giver gas også: http://medwatch.dk/secure/Medicinal___Biotek/article5985932.ece
-
selskabet skal bruge pengene til at udvile antistoffer mod CLL og MM. Direkte konkurrent til Genmab, dog noget efter
-
fik faktisk 478
-
i åbning
-
jeg tror nu faktisk godt man kan have dem liggende
-
shit
-
og at solsen kilder måske er mere end kildne
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind